Cannabidiol in pediatric drug-resistant epilepsies: A systematic review and meta-analysis of seizure responder rates and neurobehavioral outcome reporting.
BACKGROUND Cannabidiol (CBD) has emerged as an important adjunctive treatment option for pediatric drug-resistant epilepsies (DREs), particularly in developmental and epileptic encephalopathies (DEEs) such as Dravet syndrome and Lennox-Gastaut syndrome. However, the current literature remains heterogeneous and predomin...